2007, Number 2
<< Back Next >>
Med Cutan Iber Lat Am 2007; 35 (2)
Superficial mycosis in oncologic patients. A study in 98 patients
Lacy NRM, Guevara SE, de la Barreda BFl, Arce RM, Leyva SJ, Arenas R
Language: Spanish
References: 23
Page: 83-88
PDF size: 168.54 Kb.
ABSTRACT
Background and objective: Bacterial, viral and mycotic infections are highly frequent in immunocompromised patients. Superficial mycosis can increase morbidity and mortality in oncologic patients, particularly in the immunosupressed. The objective of this work is to know the frequency and etiologic agents of superficial mycotic infections in a population of immunosupressed and not immunosupressed hospitalized oncologic patients.
Material and methods: Superficial mycotic infections in ninety eight oncologic hospitalized patients in the “Instituto Nacional de Cancerología” were studied.
Results: At least one type of superficial mycosis was present in 31.6% of 98 patients. Onychomycosis (58%), athlete´s foot (38.7%), candidiasis and tinea cruris (9.6%) were the most frequent types found. Frequency was higher in immunosupressed hosts (41.1%) than in the not immunosupressed (29.6%). The most common causal agents were
T. rubrum (36.3%) and
Candida sp (11.2%).
Conclusions: Superficial mycosis are frequent in hospitalized oncologic patients, predominantly in immunosupressed hosts in which they tend to be more severe. Onychomycosis was the most common infection and, as usual, we also corroborate the higher incicdence of
T. rubrum. No systemic
infections due to superficial mycosis were found.
REFERENCES
1.Bushelman SJ, Callen PJ, Roth DN, Cohen LM. Disseminated Fusarium solani infection. J Am Acad Dermatol 1995;32:346-351.
2.Anaissie E. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infesct Dis 1992;14:43-48.
3.Herzberg JJ. Incurable, large-surface dermatomycosis in metastasizing thymoma. Hautkr Z 1979;54:319-321.
4.Bodey GP. Dermatologic manifestations of infections in neutropenic patients. Infect Dis Clin North Am 1994;8:655-675.
5.Khardori N, Hayat S, Rolston K, Bodey GP. Cuitaneous Rhizopus and Aspergillus infections in five patients with cancer. Arch Dermatol 1989;125:952-956.
6.Allo MD, Miller J, Townsend T, Tan C. Primary cutaneous aspergillosis associated with Hickman intravenous catheters. N Engl J Med 1987;317:1105-1108.
Girmenia C, Arcese W, Micozzi A et al. Onychomycosis as a possible origin of disseminated Fusarium solani in a patient with severe aplastic anemia. Clin Infect Dis 1992;14:1167.
8.Arenas R, Ocejo D. Onicomicosis: frecuencia actual en un departamento de dermatología de la Ciudad de México. Dermatología Rev Mex 1997;41:171-175.
9.Leyva J, Méndez P, Arenas R. Pie de atleta. Datos actuales sobre su causa en la Ciudad de México. Dermatología Rev Mex 1998;42:58-62.
10.Aristimuño M, Arenas R. Candidosis. Experiencia en un servicio de dermatología. Dermatología Rev Mex 1998;42:190-194.
Jones HE. Immune response and host resistance of humans to dermatophyte infection. J Am Acad Dermatol 1993;28:512-518.
Nahass GT, Meyer AJ, Campbell SF, Heaney RM. Prevalence of cutaneous findings in hospitalized medical patients. J Am Acad Dermatol 1995;33:207-211.
Dopmartin D, Dopmartin A, Delvol M y cols. Onichomycoses and AIDS. Int J Dermatol 1990;29:337-339.
Serrano-Jean L, Méndez-Tovar LJ. Onicomicosis en pacientes con síndrome de inmunodeficiencia adquirida: características clínicas y epidemiológicas. Med Cutan Ibero Lat Am 1995:23:387-389.
Ronglioletti F, Persi A, Tripodi S y cols. Proximal white subungueal onychomycosis: a sign of immunodefficiency. J Am Acad Dermatol 1994;30:129-130.
16.Chang P. La onicomicosis proximal blanca subungueal no es siempre una manifestación de inmunosupresión. Dermatología Rev Mex 1998;42:22-23.
Pierard GE, Read D, Pierard-Franchimont C, Lother Y, Rurangirwa A, Arrese-Estrada J. Cutaneous manifestations in systemic trichosporonosis. Clin Exp Dermatol 1992;17:79-82.
Daniel CR, Gupta AK, Daniel MP, Sullivan S. Candida infection of the nail: role of Candida as a primary or secondary pathogen. Int J Dermatol 1998;37:904-907.
19.Cohen PR, Maor MH. Tinea corporis confined to irradiated skin. Radiation port dermatophytosis. Cancer 1992;70:1634-1637.
20.Perduca M, Marangoni E, Guanziroli A, Romero E, Filice G. Fungaemia in hospitalized patients. Mycoses 1995;38:385-387.
Suresh JA. Disseminated Fusarium infection in an immunocompromised host. Int J Dermatol 1996;35:815-816.
22.Helm KF, Lookinfbill DP. Pityrosporum folliculitis and severe pruritus in two patients with Hodgkin disease. Arch Dermatol 1993:129:130-131.
23.Archer-Dubon C, Icaza-Chivez ME, Orozco-Topete R, Reyes E, Báez-Martínez R, Ponce de León S, An epidemic outbreak of Malassezia folliculitis in three adult patients in an intensive care unit: a previously unrecongnized nosocomial infection. Int J Dermatol 1999;38:453-456.